Infant pertussis and maternal immunity: The curious case of Canada

Natasha S Crowcroft1, Shelly Bolotin2, Ye Li3

  • 1Dalla Lana School of Public Health, University of Toronto, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Canada; ICES, Toronto, Canada.

Vaccine
|March 22, 2021
PubMed

Insights

Past pertussis outbreaks in children may lower infant risk when those children become parents. As these cohorts age, Canada

Area of Science:

  • Epidemiology
  • Immunology
  • Public Health

Background:

  • The United Kingdom (UK) and Canada utilize the same acellular pertussis vaccine.
  • Both nations experienced significant pertussis (whooping cough) outbreaks historically.
  • Despite similar vaccines and past outbreaks, current pertussis epidemiology differs between the UK and Canada.

Purpose of the Study:

  • To investigate the hypothesis that childhood pertussis outbreaks influence future pertussis risk in the same individuals when they reach reproductive age.

Main Methods:

  • Ecological birth cohort analysis of women of childbearing age in England and Wales, and Canada.
  • Comparison of the relative risk of pertussis infection at baseline (1992) and two subsequent time points (2002, 2012).
  • Forecasting pertussis risk trends in Canada to 2022, assuming stable incidence.

Main Results:

  • In Canada, the cumulative risk of pertussis remained similar in 2002 and 2012, and was higher than in 1992.
  • In England and Wales, cumulative pertussis risk decreased significantly between 1992 and 2012.
  • Projected 2022 data suggests Canada's pertussis risk pattern may increasingly resemble that of England and Wales.

Conclusions:

  • Widespread childhood pertussis outbreaks may confer reduced risk of infection for infants born to parents who experienced these outbreaks.
  • The precise mechanism requires further investigation.
  • As cohorts exposed to past outbreaks age out of their childbearing years, Canada may see an increased pertussis burden in infants, mirroring UK trends.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
570
Vaccinations01:51

Vaccinations

Overview
49.1K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
646
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
9.3K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
14.2K